Familial Mediterranean Fever (FMF )

DBCOND0067538Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesDisease and Non-Disease Concepts, Unclassified

Familial Mediterranean Fever (FMF ) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Familial Mediterranean Fever · Familial Mediterranean Fever (FMF) · Familial Mediterranean Syndrome
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0016320ICD-10M04.1SNOMED CT12579009MedDRA10016207UMLSC0031069

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
21Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Familial Mediterranean Fever (FMF ) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In